OptimizeRx Corporation (OPRX) Earnings Call Transcript

Hello, ladies and gentlemen. Will the meeting please come to order. I want to welcome all of you to the annual meeting of the shareholders of OptimizeRx Corporation. I am Will Febbo, CEO and member of the Board of OptimizeRx. And I'll be presiding at this meeting. Also present at the meeting today are our Chief Financial Officer, Doug Baker. Doug Baker will act as secretary of the meeting. Barry Shapiro from Broadridge has been appointed to act as the inspector of election. Michelle Felmlee, a representative from UHY, our independent auditors, is also present at the meeting, and she will be available to answer questions concerning the company's financial statements. The secretary has an affidavit of mailing, establishing the notice of this meeting was duly given. A copy of the notice of meeting and the affidavit of meeting will be incorporated into the minutes of this meeting. All shareholders of record at the close of business, September 28, 2020, are entitled to vote at the annual meeting. Our first order of business at this meeting is to determine whether the shares represented at the meeting, either in person or by proxy, are sufficient to constitute a quorum for the purpose of the transacting business. Doug, do you have a report?

Yes. The shareholders' list shows that holders of 15,043,041 shares of common stock of the company are entitled to vote at this meeting. We are informed by Barry Shapiro that are represented in person or by proxy 10,992,240 shares of common stock or approximately 73% of all shares entitled to vote at this meeting.

Thank you. Because holders of a majority of the shares entitled to vote at this meeting are present in person or by proxy, I declare this meeting to be duly convened for the purpose of transacting such business as may be properly come before it. The next order of business is to describe the matters to be voted on today's meeting. Proposal number one, election of directors. The first proposal before the shareholders of the company is the election of 6 directors to serve until the annual meeting of shareholders in 2021 and until their successors are duly elected and qualified. The management of the company recommends the election of the following persons as directors of the company: Gus Halas, Jim Lang, Lynn Vos, Patrick Spangler, Will Febbo and Greg Wasson. Proposal number two, approval of the OptimizeRx Corporation's 2013 equity compensation plan. The second proposal before the shareholder is approval of the OptimizeRx Corporation 2013 equity compensation plan and authorizing up to the total of 3 million shares of common stock to be issued under the plan. Proposal number three, ratification of the appointment of UHY as independent public accountant for the fiscal year ending December 31, 2020. Opening the polls. The polls are now open. If there are any shareholders who have not yet voted who wish to vote, you may do so by clicking on the Voting button on the web portal and following the instructions there. If you previously voted by proxy, you do not need to vote today unless you wish to change your vote. [Voting]

Okay. Now that everyone has had the opportunity to vote, I hereby declare that the polls are closed. The ballots and proxies will be held in the possession of the inspector of election. The inspector of election will count the votes. Inspector, have the ballots been counted?